英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Febuxostat Impurity 4 |
非布索坦雜質(zhì)4(非布司他雜質(zhì)) |
1335202-59-9 |
詳細(xì)
|
Febuxostat Related Compound A |
非布司他雜質(zhì)A(非布司他雜質(zhì)) |
1239233-86-3 |
詳細(xì)
|
Febuxostat Impurity 16 |
非布索坦雜質(zhì)16(非布司他雜質(zhì)) |
407582-48-3 |
詳細(xì)
|
Febuxostat Impurity 8 |
非布索坦雜質(zhì)8(非布司他雜質(zhì)) |
161797-99-5 |
詳細(xì)
|
MILRINONE RELATED COMPOUND A (50 MG) (1,6-DIHYDRO-2-METHYL-6-OXO(3,4'-BIPYRIDINE)-5-CAR-BOXAMIDE) |
米力農(nóng)相關(guān)化合物A(50毫克)(1,6-二氫- 2 -甲基- 6 -氧(3,4'-聯(lián)吡啶)-5 -甲酰胺) |
80047-24-1 |
詳細(xì)
|
Vortioxetine Impurity 26 |
沃替西汀雜質(zhì)26 |
2137588-68-0 |
詳細(xì)
|
Vortioxetine Impurity 1 |
沃替西汀雜質(zhì)A |
1293489-71-0 |
詳細(xì)
|
1-[2-[(2,6-diMethylphenyl)thio]phenyl]- Piperazine |
沃替西汀雜質(zhì)F |
508233-76-9 |
詳細(xì)
|
Vortioxetine Impurity 4 |
沃替西汀雜質(zhì)4 |
1293489-77-6 |
詳細(xì)
|
1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine |
沃替西汀雜質(zhì)C |
1293489-74-3 |
詳細(xì)
|
Vortioxetine impurity S |
沃替西汀雜質(zhì)S |
1815608-51-5 |
詳細(xì)
|
Vortioxetine Imp.E |
沃替西汀雜質(zhì)E |
508233-77-0 |
詳細(xì)
|
6-Aminouracil |
4-氨基-2,6-二羥基嘧啶(伊曲茶堿) |
873-83-6 |
詳細(xì)
|
2,4(1H,3H)-Pyrimidinedione, 6-amino-1,3-diethyl-5-nitro- |
伊曲茶堿雜質(zhì) 4 |
146946-10-3 |
詳細(xì)
|
Vortioxetine Impurity 3 |
沃替西汀雜質(zhì)3 |
508233-82-7 |
詳細(xì)
|
Vortioxetine Impurity D |
沃替西汀雜質(zhì)D |
508233-75-8 |
詳細(xì)
|
Istradefylline Impurity 10 |
伊曲茶堿二聚體雜質(zhì) |
1019659-02-9 |
詳細(xì)
|
2,4(1H,3H)-Pyrimidinedione, 6-amino-3-ethyl- |
伊曲茶堿雜質(zhì) |
21237-00-3 |
詳細(xì)
|
Itraphylline impuritie7 |
伊曲茶堿雜質(zhì)7 |
155272-03-0 |
詳細(xì)
|
Celecoxib iMpurity-G |
塞來(lái)昔布雜質(zhì)G |
1061214-06-9 |
詳細(xì)
|
Celecoxib Impurity 11 |
塞來(lái)昔布雜質(zhì)11 |
219986-64-8 |
詳細(xì)
|
Celecoxib Impurity 2 |
塞來(lái)昔布雜質(zhì)2 |
948293-46-7 |
詳細(xì)
|
4,4,4-Trifluoro-1-phenyl-1,3-butanedione |
苯甲酰三氟丙酮(塞來(lái)昔布雜質(zhì)) |
326-06-7 |
詳細(xì)
|
Celecoxib Impurity 30 |
塞來(lái)昔布雜質(zhì)30(塞來(lái)昔布雜質(zhì)) |
53764-99-1 |
詳細(xì)
|
Methyl 2-fluoro-4-((1-methoxy-2-methyl-1-oxopropan-2-yl)amino)benzoate |
2-氟-4-[(1-甲氧基-2-甲基-1-氧代-2-丙基)氨基]苯甲酸甲酯(恩雜魯胺雜質(zhì)) |
1802242-47-2 |
詳細(xì)
|
Enzalutamide Impurity 7 |
恩雜魯胺雜質(zhì)7 |
1332524-02-3 |
詳細(xì)
|
Enzalutamide Impurity I |
恩雜魯胺雜質(zhì)I |
2030242-21-6 |
詳細(xì)
|
Acotiamide impurity 5 |
尼克酰胺雜質(zhì)5(阿考替胺雜質(zhì)) |
206882-15-7 |
詳細(xì)
|
Acotiamide impurity C |
阿考替安雜質(zhì)C |
1824734-16-8 |
詳細(xì)
|
Elagolix Impurity 9 |
噁拉戈利雜質(zhì)9 |
2316733-81-8 |
詳細(xì)
|
Vonoprazan Impurity 14 |
沃諾拉贊雜質(zhì)14 |
1807642-39-2 |
詳細(xì)
|
Celebrex P |
塞來(lái)昔布雜質(zhì)P |
921617-76-7 |
詳細(xì)
|
Celecoxib Carboxylic Acid |
羧酸塞來(lái)昔布(塞來(lái)昔布雜質(zhì)) |
170571-01-4 |
詳細(xì)
|
Finasteride Impurity 8 |
非那雄胺雜質(zhì)8 |
4640-41-9 |
詳細(xì)
|
N-Methyl OMeprazole (Mixture of isoMers with the Methylated nitrogens of iMidazole) |
埃索美拉唑雜質(zhì)H193/61 |
89352-76-1 |
詳細(xì)
|
ethyl 2-(2-(4-hydroxyphenyl)thiazol-4-yl)acetate |
2-(4-羥基苯基)-4-噻唑乙酸乙酯(非布司他雜質(zhì)) |
886503-50-0 |
詳細(xì)
|
Febuxostat Impurity 5 |
非布索坦雜質(zhì)5(非布司他雜質(zhì)) |
1206550-99-3 |
詳細(xì)
|
Febuxostat Impurity S |
非布索坦雜質(zhì)S(非布司他雜質(zhì)) |
1330632-48-8 |
詳細(xì)
|
Enzalutamide Impurity J |
恩雜魯胺雜質(zhì)J |
1242137-18-3 |
詳細(xì)
|
N-[3-Fluoro-4-[(MethylaMino)carbonyl]phenyl]-2-Methylalanine |
N-[3-氟-4-[(甲基氨基)羰基]苯基]-2-甲基丙氨酸(恩雜魯胺雜質(zhì)) |
1289942-66-0 |
詳細(xì)
|
Enzalutamide impurity B |
恩雜魯胺雜質(zhì)B |
749927-69-3 |
詳細(xì)
|
Enzalutamide Impurity M |
安扎魯胺雜質(zhì)M(恩雜魯胺雜質(zhì)) |
1242137-15-0 |
詳細(xì)
|
5-amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile |
3-氨基-5-(4-苯氧基苯基)-4-氰基-1H-吡唑(伊魯替尼中間體) |
330792-70-6 |
詳細(xì)
|
2-(Methoxy(4-phenoxyphenyl)Methylene)Malononitrile |
2-(甲氧基(4-苯氧基苯基)亞甲基)丙二腈(伊魯替尼中間體) |
330792-69-3 |
詳細(xì)
|
Methyl 4-bromo-2-fluorobenzoate |
2-氟-4-溴苯甲酸甲酯(恩雜魯胺雜質(zhì)) |
179232-29-2 |
詳細(xì)
|
Enzalutamide Impurity 33 |
恩雜魯胺雜質(zhì)33(恩雜魯胺雜質(zhì)) |
1839619-50-9 |
詳細(xì)
|
Mometasone Furoate Impurity Q |
糠酸莫米松雜質(zhì)Q |
83881-08-7 |
詳細(xì)
|
Mometasone Furoate EP Impurity M |
糠酸莫米松雜質(zhì)M |
57780-86-6 |
詳細(xì)
|
1,4-ANDROSTADIEN-11-BETA-OL-3,17-DIONE |
甲基潑尼松龍雜質(zhì)3 |
898-84-0 |
詳細(xì)
|
Febuxostat Impurity 14 |
非布索坦雜質(zhì)14(非布司他雜質(zhì)) |
1335202-60-2 |
詳細(xì)
|
Febuxostat Impurity 19 |
非布索坦雜質(zhì)19(非布司他雜質(zhì)) |
1330632-47-7 |
詳細(xì)
|
Febuxostat Impurity 58 |
非布索坦雜質(zhì)58(非布司他雜質(zhì)) |
886501-78-6 |
詳細(xì)
|
Febuxostat Impurity K |
非布索坦雜質(zhì)K(非布司他雜質(zhì)) |
144060-52-6 |
詳細(xì)
|
Febuxostat Impurity 8 |
非布索坦 雜質(zhì)8(非布司他雜質(zhì)) |
144060-62-8 |
詳細(xì)
|
Febuxostat Impurity H |
非布司他雜質(zhì)H(非布司他雜質(zhì)) |
1239233-87-4 |
詳細(xì)
|
FeBuxostat Impurity 26 |
非布索坦雜質(zhì)26(非布司他雜質(zhì)) |
1886961-39-2 |
詳細(xì)
|
Febuxostat Impurity 59 |
非布索坦雜質(zhì)59(非布司他雜質(zhì)) |
2418591-42-9 |
詳細(xì)
|
Febuxostat Impurity 13 |
非布索坦雜質(zhì)13(非布司他雜質(zhì)) |
1330632-46-6 |
詳細(xì)
|
2-(2-Methylthiazol-5-yl)acetic acid |
(2-甲基噻唑-5-基)乙酸(非布司他雜質(zhì)) |
52454-65-6 |
詳細(xì)
|
Febuxostat Impurity 63 |
非布司他/非布索坦雜質(zhì)63(非布司他雜質(zhì)) |
138330-01-5 |
詳細(xì)
|
Febuxostat Impurity Z10 |
非布索坦雜質(zhì)Z10(非布司他雜質(zhì)) |
5203-15-6 |
詳細(xì)
|
Celecoxib Impurity A |
塞來(lái)昔布雜質(zhì)A |
170570-01-1 |
詳細(xì)
|
Celecoxib Impurity 3 |
塞來(lái)昔布雜質(zhì)3 |
170569-87-6 |
詳細(xì)
|
Celecoxib Impurity F |
塞來(lái)昔布雜質(zhì)F |
170569-99-0 |
詳細(xì)
|
Acotiamide Hydrochloride impurity F |
鹽酸阿考替胺雜質(zhì)F |
185106-01-8 |
詳細(xì)
|
Acotiamide Impurity 10 |
阿考替胺雜質(zhì)10 |
1809272-85-2 |
詳細(xì)
|
Acotiamide Hydrochloride impurity K |
鹽酸阿考替胺雜質(zhì)K |
701197-05-9 |
詳細(xì)
|
2-(Hydroxy(4-phenoxyphenyl)methylene)malononitrile |
2-[羥基(4-苯氧基苯基)亞甲基]丙二腈(伊魯替尼中間體) |
330792-68-2 |
詳細(xì)
|
AcotiaMide |
阿考替胺 |
185106-16-5 |
詳細(xì)
|
2-Ethyl Milrinone |
米力農(nóng)雜質(zhì)E |
78504-63-9 |
詳細(xì)
|
2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid |
米力農(nóng)雜質(zhì)G |
80047-38-7 |
詳細(xì)
|
Vortioxetine Impurity 22 |
沃替西汀雜質(zhì)22 |
2476761-84-7 |
詳細(xì)
|
Milrinone Impurity 15 |
米力農(nóng)雜質(zhì)15 |
156033-07-7 |
詳細(xì)
|
3-[(4-AMino-2-Methyl-5-pyriMidinyl)Methyl]-4-Methyl-5-[2-(sulfooxy)ethyl]thiazoliuM Inner Salt |
硫胺雜質(zhì)A(VB1,磺酸酯);鹽酸硫胺素EP雜質(zhì)A |
2380-61-2 |
詳細(xì)
|
1,3-Diazepane-2,4,6-trione |
1,3-高哌嗪-2,4,6-三酮(米力農(nóng)相關(guān)) |
338756-68-6 |
詳細(xì)
|
METHYL 4-METHYLCINNAMATE |
奧扎格雷中間體雜質(zhì)2 |
20754-20-5 |
詳細(xì)
|
Ozagrel Impurity 38 |
奧扎格雷雜質(zhì)38 |
24393-49-5 |
詳細(xì)
|
Ozagrel Impurity 38 |
奧扎格雷雜質(zhì)38 |
20511-20-0 |
詳細(xì)
|
Vonoprazan Impurity X Fumaric acid |
沃諾拉贊雜質(zhì)X富馬酸 |
928325-82-0 |
詳細(xì)
|
Vonoprazan Impurity U9 |
沃諾拉贊雜質(zhì)U9 |
1885094-62-1 |
詳細(xì)
|
4-Methylcinnamic acid |
對(duì)甲基肉桂酸(奧扎格雷鈉雜質(zhì)) |
1866-39-3 |
詳細(xì)
|
Ozagrel Impurity 37 |
3-(4-(羥甲基)苯基)丙烯酸乙酯(奧扎格雷鈉) |
530145-11-0 |
詳細(xì)
|
1-[2-[(2,4-diMethylphenyl)sulfinyl]phenyl]- Piperazine |
沃替西汀雜質(zhì)D |
1429908-35-9 |
詳細(xì)
|
Vortioxetine Impurity 2 |
沃替西汀雜質(zhì)2 |
1293489-69-6 |
詳細(xì)
|
Febuxostat Impurity 27 |
非布索坦雜質(zhì)27(非布司他雜質(zhì)) |
7753-13-1 |
詳細(xì)
|
4-HYDROXYTHIOBENZAMIDE |
4-羥基硫代苯甲酰胺(非布司他雜質(zhì)) |
25984-63-8 |
詳細(xì)
|
Febuxostat Impurity 61 |
非布索坦雜質(zhì)61(非布司他雜質(zhì)) |
168780-80-1 |
詳細(xì)
|
Febuxostat Impurity 9 |
非布索坦雜質(zhì)9(非布司他雜質(zhì)) |
1657014-33-9 |
詳細(xì)
|
Febuxostat Impurity 64 |
非布索坦雜質(zhì)64(非布司他雜質(zhì)) |
923942-36-3 |
詳細(xì)
|
Febuxostat Impurity 17 |
非布索坦雜質(zhì)17(非布司他雜質(zhì)) |
1530308-87-2 |
詳細(xì)
|
Febuxostat Impurity 7 |
非布司他雜質(zhì)7(非布司他雜質(zhì)) |
1350352-70-3 |
詳細(xì)
|
FeBuxostat Impurity 18 |
非布索坦雜質(zhì)18(非布司他雜質(zhì)) |
1312815-35-2 |
詳細(xì)
|
Febuxostat Impurity 70 |
非布司他雜質(zhì) |
2418591-43-0 |
詳細(xì)
|
Enzalutamide Impurity O |
恩雜魯胺雜質(zhì)O |
915087-16-0 |
詳細(xì)
|
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine methyl ester |
N-[3-氟-4-[(甲基氨基)羰基]苯基]-2-甲基丙氨酸甲酯(恩雜魯胺雜質(zhì)) |
1332524-01-2 |
詳細(xì)
|
Methyl5-chloro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate |
5-氯-2,6-二氧代-1,2,3,6-四氫嘧啶-4-羧酸甲酯(曲格列汀雜質(zhì)) |
91447-90-4 |
詳細(xì)
|
Benzenesulfonamide, 4-[2-(1-phenylethylidene)hydrazinyl]- |
塞來(lái)昔布雜質(zhì) |
1135952-91-8 |
詳細(xì)
|
Ozagrel Impurity 38 |
奧扎格雷雜質(zhì)38 |
97585-04-1 |
詳細(xì)
|
4-ethoxy-3-(4-pyridyl)-3-buten-2-one |
米力農(nóng)雜質(zhì)H |
88349-61-5 |
詳細(xì)
|
5-Thiazolecarboxylic acid, 2-[3-carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-, 5-methyl ester |
非布司他雜質(zhì)(非布司他雜質(zhì)) |
2476465-39-9 |
詳細(xì)
|